
Hologic (HOLX) Earnings Dates & Reports
Hologic (HOLX) Most Recent Earnings
Report DateMay 1, 2025
Period EndingQ2 2025
Est. EPS$1.02
Actual EPS$1.03
EarningsBeat
Hologic (HOLX) Earnings
View the latest Hologic (HOLX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Hologic (HOLX)
Order type
Buy in
Order amount
Est. shares
0 shares
Hologic (HOLX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Hologic (HOLX) Latest Earnings
The value each HOLX share was expected to gain vs. the value each share gained.
Hologic (HOLX) reported its most recent earnings on May 1, 2025 for Q2 2025, posting earnings per share (EPS) of $1.03. This exceeded analysts' expectations of $1.02 by 0.98%, marking a Beat.
For comparison, Hologic reported EPS of $1.03 in the same quarter last year.
The company is expected to announce its next earnings report on 07/28/2025, with analysts projecting an EPS of $1.05.
Hologic (HOLX) Earnings History
Hologic (HOLX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Hologic’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 1, 2025 | — | — | — |
Feb 5, 2025 | — | — | — |
Nov 4, 2024 | — | — | — |
Jul 29, 2024 | — | — | — |
Hologic (HOLX) Earnings FAQs
Hologic (HOLX) last reported earnings on May 1, 2025 for Q2 2025, posting an EPS of $1.03, which Beat the estimate of $1.02 by 0.98%.
For Q2 2025, Hologic (HOLX) reported an EPS of $1.03, exceeding analysts' estimate of $1.02 by 0.98%.
For Q2 2025, Hologic (HOLX) Beat expectations with an actual EPS of $1.03 vs. an estimated EPS of $1.02.
Following the last earnings report on May 1, 2025, Hologic (HOLX)'s stock price moved — from — to —.
The next Hologic (HOLX) earnings call is scheduled for Jul. 28, 2025, where executives will discuss financial results and outlook.